Joseph Piscitelli

454 total citations
19 papers, 365 citations indexed

About

Joseph Piscitelli is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Joseph Piscitelli has authored 19 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Oncology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Joseph Piscitelli's work include Monoclonal and Polyclonal Antibodies Research (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Melanoma and MAPK Pathways (3 papers). Joseph Piscitelli is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Melanoma and MAPK Pathways (3 papers). Joseph Piscitelli collaborates with scholars based in United States, Spain and France. Joseph Piscitelli's co-authors include William C. Zamboni, Andrew T. Lucas, Lauren Price, Allison N. Schorzman, Samuel K. Lai, M. Gregory Forest, Morgan D. McSweeney, Yanguang Cao, Timothy Wessler and János Szebeni and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Advanced Drug Delivery Reviews.

In The Last Decade

Joseph Piscitelli

18 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph Piscitelli United States 9 126 113 100 95 65 19 365
Michael L. Manning United States 6 128 1.0× 79 0.7× 40 0.4× 115 1.2× 60 0.9× 7 333
Uli Binder Germany 10 345 2.7× 92 0.8× 190 1.9× 54 0.6× 126 1.9× 12 564
Wuwei Yang China 11 116 0.9× 124 1.1× 38 0.4× 87 0.9× 70 1.1× 21 614
Mark G.P. Saifer United States 7 278 2.2× 33 0.3× 99 1.0× 127 1.3× 70 1.1× 8 574
Young Seok Cho South Korea 12 167 1.3× 76 0.7× 60 0.6× 87 0.9× 103 1.6× 27 411
Susan Hoppmann United States 12 213 1.7× 103 0.9× 158 1.6× 22 0.2× 75 1.2× 14 471
Huangliang Zheng China 12 119 0.9× 46 0.4× 27 0.3× 82 0.9× 138 2.1× 17 411
Michela Varani Italy 11 63 0.5× 64 0.6× 87 0.9× 49 0.5× 23 0.4× 29 328
Xiaoling Zheng China 14 134 1.1× 120 1.1× 48 0.5× 62 0.7× 48 0.7× 40 539
Marta Sevieri Italy 14 162 1.3× 68 0.6× 24 0.2× 126 1.3× 26 0.4× 26 428

Countries citing papers authored by Joseph Piscitelli

Since Specialization
Citations

This map shows the geographic impact of Joseph Piscitelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Piscitelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Piscitelli more than expected).

Fields of papers citing papers by Joseph Piscitelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Piscitelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Piscitelli. The network helps show where Joseph Piscitelli may publish in the future.

Co-authorship network of co-authors of Joseph Piscitelli

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Piscitelli. A scholar is included among the top collaborators of Joseph Piscitelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Piscitelli. Joseph Piscitelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Elmeliegy, Mohamed, Andrea Viqueira, Erik Vandendries, et al.. (2025). Dose Optimization of Elranatamab to Mitigate the Risk of Cytokine Release Syndrome in Patients with Multiple Myeloma. Targeted Oncology. 20(2). 349–359. 2 indexed citations
2.
3.
Piscitelli, Joseph, Micaela B. Reddy, Lance Wollenberg, et al.. (2024). Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin Coadministration. Clinical Pharmacokinetics. 63(4). 483–496. 4 indexed citations
4.
Piscitelli, Joseph, Micaela B. Reddy, Lance Wollenberg, et al.. (2024). Evaluation of the effect of modafinil on the pharmacokinetics of encorafenib and binimetinib in patients with BRAF V600-mutant advanced solid tumors. Cancer Chemotherapy and Pharmacology. 94(3). 337–347. 1 indexed citations
5.
Piscitelli, Joseph, Bart Hens, Lance Wollenberg, et al.. (2023). Effect of Food and a Proton-Pump Inhibitor on the Absorption of Encorafenib: An In Vivo–In Vitro–In Silico Approach. Molecular Pharmaceutics. 20(5). 2589–2599. 12 indexed citations
6.
7.
Piscitelli, Joseph, Mina Nikanjam, Edmund V. Capparelli, et al.. (2023). Fexofenadine Plasma Concentrations to Estimate Systemic Exposure in Healthy Adults Using a Limited Sampling Strategy with a Population Pharmacokinetic Approach. Therapeutic Drug Monitoring. 45(4). 539–545. 2 indexed citations
8.
Luterbach, Courtney, Hongqiang Qiu, Rajnikant Sharma, et al.. (2022). A Systems-Based Analysis of Mono- and Combination Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections. Antimicrobial Agents and Chemotherapy. 66(10). e0059122–e0059122. 12 indexed citations
9.
Piscitelli, Joseph, et al.. (2022). The Effect of Hepatic Impairment on the Pharmacokinetics of Dacomitinib. Clinical Drug Investigation. 42(3). 221–235. 4 indexed citations
10.
Elmeliegy, Mohamed, Andrea Viqueira, Erik Vandendries, et al.. (2022). Dose Optimization to Mitigate the Risk of CRS with Elranatamab in Multiple Myeloma. Blood. 140(Supplement 1). 7174–7175. 12 indexed citations
11.
Price, Lauren, Joseph Piscitelli, Charlene Santos, et al.. (2021). Minibeam radiation therapy enhanced tumor delivery of PEGylated liposomal doxorubicin in a triple-negative breast cancer mouse model. Therapeutic Advances in Medical Oncology. 13. 4277465732–4277465732. 5 indexed citations
12.
Mehta, Rashmi, Joseph Piscitelli, Adrian J. Wolstenholme, et al.. (2020). The Effect of Moderate- and High-Fat Meals on the Bioavailability of Dolutegravir/Rilpivirine Fixed-Dose Combination Tablet. SHILAP Revista de lepidopterología. 1 indexed citations
13.
Mehta, Rashmi, Joseph Piscitelli, Caifeng Fu, et al.. (2020). <p>The Effect of Moderate- and High-Fat Meals on the Bioavailability of Dolutegravir/Rilpivirine Fixed-Dose Combination Tablet</p>. Clinical Pharmacology Advances and Applications. Volume 12. 49–52. 3 indexed citations
14.
McSweeney, Morgan D., Lauren Price, Timothy Wessler, et al.. (2019). Overcoming anti-PEG antibody mediated accelerated blood clearance of PEGylated liposomes by pre-infusion with high molecular weight free PEG. Journal of Controlled Release. 311-312. 138–146. 70 indexed citations
15.
16.
McSweeney, Morgan D., Timothy Wessler, Lauren Price, et al.. (2018). A minimal physiologically based pharmacokinetic model that predicts anti-PEG IgG-mediated clearance of PEGylated drugs in human and mouse. Journal of Controlled Release. 284. 171–178. 66 indexed citations
17.
Zamboni, William C., János Szebeni, Serguei Kozlov, et al.. (2018). Animal models for analysis of immunological responses to nanomaterials: Challenges and considerations. Advanced Drug Delivery Reviews. 136-137. 82–96. 46 indexed citations
18.
Lucas, Andrew T., et al.. (2018). Factors Affecting the Pharmacology of Antibody–Drug Conjugates. Antibodies. 7(1). 10–10. 89 indexed citations
19.
Gaffney, Edwin V., et al.. (1987). Quantitation of human interleukin-1β with polyclonal antibodies. Journal of Immunological Methods. 101(2). 271–277. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael L. Manning Breakdown of academic impact, for papers by Uli Binder Breakdown of academic impact, for papers by Wuwei Yang Breakdown of academic impact, for papers by Mark G.P. Saifer Breakdown of academic impact, for papers by Young Seok Cho Breakdown of academic impact, for papers by Susan Hoppmann Breakdown of academic impact, for papers by Huangliang Zheng Breakdown of academic impact, for papers by Michela Varani Breakdown of academic impact, for papers by Xiaoling Zheng Breakdown of academic impact, for papers by Marta Sevieri
Rankless by CCL
2026